Drugs giant Pfizer has announced plans to close two of its three key UK supply sites, but insists the decision has nothing to do with Brexit.
According to media reports, the firm’s manufacturing site in Park Royal, London, as well as its global cold chain packaging and distribution facility in Portsmouth will be closed in 2017 and 2020 respectively, with around 370 job losses in total.
“This review process has been going on since 2010 and the team just felt there were more production capabilities at the site in Belgium to support future demand and to ensure we can support the supply chain,” explained a spokesman for the firm, as reported by The Telegraph.
“The UK has a tricky commercial environment and doesn’t always link life sciences investment to the way patients use medicines, but this decision is not linked to Brexit or medicines access”.
Pfizer sold its flagship UK facilities in Sandwich, Kent, back in 2012, but around 700 of its employees remain employed at the Discovery Park science and business hub which is now housed there, and it still currently employs around 2,700 people at sites across the country.
By Selina McKee
Source: Pharma Times
Giovanni Caforio, the former CEO of Bristol Myers Squibb, is set to become the next board chairman of Novartis, which on Tuesday proposed the pharmaceutical industry veteran as its pick to replace Joerg Reinhardt in the role next year. Reinhardt has served as Novartis’ chair since 2013 and plans to retire when his 12-year term ends in 2025.
GE HealthCare has raised the curtain on two ultrasound systems equipped with artificial intelligence programs designed to assist in diagnosing conditions in women’s health, including obstetric exams. The Voluson Signature 20 and 18 imaging systems include AI tools capable of automatically identifying and annotating measurements of fetal anatomy.
Scientists from the University of Edinburgh’s School of Chemistry have revealed a new sustainable method of manufacturing complex molecules that could reduce waste produced during drug production. The method published in Nature Chemistry could help to prevent severe side effects caused by drugs that can exist as enantiomers.
